Á lódáil...
Ipratropium bromide versus short acting beta‐2 agonists for stable chronic obstructive pulmonary disease
BACKGROUND: Chronic obstructive pulmonary disease (COPD) is a condition associated with high morbidity, mortality and cost to the community. Patients often report symptomatic improvement with short‐acting beta‐2 agonists (SABA) and anticholinergic bronchodilator medications, and both are recommended...
Na minha lista:
| Foilsithe in: | Cochrane Database Syst Rev |
|---|---|
| Main Authors: | , , , , , , , |
| Formáid: | Artigo |
| Teanga: | Inglês |
| Foilsithe: |
John Wiley & Sons, Ltd
2006
|
| Rochtain Ar Líne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6513456/ https://ncbi.nlm.nih.gov/pubmed/16625543 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD001387.pub2 |
| Clibeanna: |
Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!
|